Puma biotechnology press release top
Puma biotechnology press release top
Puma biotechnology press release top
Puma biotechnology press release top
Puma biotechnology press release top
Puma biotechnology press release top

Puma biotechnology press release top

Puma biotechnology press release top, Puma Biotech Q3 Profit Soars 250 to 20.3M Raises 2024 Guidance PBYI Stock News top

$54.00

SKU: 7523819

Colour
  • Puma biotechnology shop press release
  • Puma Biotechnology Biotechnology The Pharmaletter The Pharmaletter
  • Puma Biotechnology Reports Results of PB272 neratinib in P III NALA Trial for Patients with 2L HER2 Metastatic Breast Cancer ASCO2019
  • A New Drug on the Horizon for HER2 Breast Cancer Patients Avise Analytics
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus